Vertex Pharmaceuticals (VRTX) Goodwill (2009 - 2026)

Vertex Pharmaceuticals has reported Goodwill for 18 years, with the latest figure at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Goodwill changed 0.0% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (changed 0.0% YoY), and the FY2025 full-year result was $1.1 billion, changed 0.0% from the prior year.
• Goodwill for Q1 2026 stood at $1.1 billion, roughly flat from $1.1 billion in the prior quarter.
• The five-year high for Goodwill was $1.1 billion in Q4 2022, with the low at $1.0 billion in Q1 2022.
• Average Goodwill over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
• Year-over-year, Goodwill advanced 10.0% in 2022 and retreated 1.09% in 2023.
• Tracing VRTX's Goodwill over 5 years: stood at $1.1 billion in 2022, then decreased by 1.09% to $1.1 billion in 2023, then changed by 0.0% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025, then changed by 0.0% to $1.1 billion in 2026.
• The last three Goodwill figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison